01 September 2005
Stability of infectious recombinant adeno-associated viral vector in gene delivery.
Ruian Xu, Mehdi Rahimi, Hsu Ma, Peter Fung, Chunqi Chang, Sue Xu, Matthew DuringMed Sci Monit 2005; 11(9): BR305-308 :: ID: 428440
Abstract
Background: The aim of this study is to provide a basis for the designof appropriate protocols for the shipping and storage of rAAV vectors for experimental laboratory studiesand clinical trials. Material/Methods: rAAV stocks were generated by standard methods and then subjectedto different environments. The transduction efficiency of viral vectors both in vitro and in vivo wasdetermined by luciferase activity and immunohistochemistry. Results: The virus stored at -80 degreesC remained completely stable and had high transduction efficiency. By contrast, the transduction efficiencyof all other groups on 293 cells decreased continuously over time. The transduction efficiency of the-20 degrees C group remained relatively high for the first 5 days, but dropped sharply between days 5and 7. The transduction efficiency for the 4 degrees C group dropped sharply on both days 1 and 7, andcontinued to decrease to 55% of maximum efficiency by the end of the first month. For both the room temperature(RT) and 37 degrees C groups, a sharp fall in efficiency was observed at day 1, and efficiency continuedto decline throughout the experimental period. Data from the in vivo study also revealed that rAAV vectorstored at -80 degrees C remained stable and retained its transduction efficiency. Conclusions: The virusstored at -80 degrees C remained completely stable and retained high transduction efficiency. The implicationsof these findings provide a basis for viral stock portioning and avoidance of freeze-thawing and storingat temperatures above -80 degrees C prior to clinical trials.
Keywords: Cell Line, Cryopreservation, Dependovirus - genetics, genetic therapy, Genetic Vectors, Luciferases - genetics, Rats, Wistar, Recombinant Proteins - genetics, Recombination, Genetic, Temperature, Transduction, Genetic
Editorial
01 March 2024 : Editorial
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-ThalassemiaDOI: 10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
In Press
18 Mar 2024 : Clinical Research
Sexual Dysfunction in Women After Tibial Fracture: A Retrospective Comparative StudyMed Sci Monit In Press; DOI: 10.12659/MSM.944136
21 Feb 2024 : Clinical Research
Potential Value of HSP90α in Prognosis of Triple-Negative Breast CancerMed Sci Monit In Press; DOI: 10.12659/MSM.943049
22 Feb 2024 : Review article
Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...Med Sci Monit In Press; DOI: 10.12659/MSM.943168
23 Feb 2024 : Clinical Research
A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...Med Sci Monit In Press; DOI: 10.12659/MSM.943732
Most Viewed Current Articles
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952